Lead induced disorders in hematopoietic and drug metabolizing enzyme system and their protection by ascorbic acid supplementation

Biomedical and Environmental Sciences

Volumn 11, Issue 1, 1998, Pages 7-14

  Vij, Anjana G ^a   Satija, N K ^a   Flora, S J S ^b  

^a DEFENCE INSTITUTE OF PHYSIOLOGY AND ALLIED SCIENCES   (India)

^b DEFENCE RESEARCH AND DEVELOPMENT ESTABLISHMENT   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ASCORBIC ACID; HEME; LEAD; MIXED FUNCTION OXIDASE; PORPHOBILINOGEN DEAMINASE; PORPHOBILINOGEN SYNTHASE; THIOL DERIVATIVE; UNSPECIFIC MONOOXYGENASE;

ANIMAL; ARTICLE; BIOSYNTHESIS; BLOOD; DRUG EFFECT; ENZYMOLOGY; HEMATOPOIESIS; KIDNEY; LEAD POISONING; LIVER; LIVER MICROSOME; MALE; METABOLISM; ORAL DRUG ADMINISTRATION; RAT;

ADMINISTRATION, ORAL; ANILINE HYDROXYLASE; ANIMALS; ASCORBIC ACID; HEMATOPOIESIS; HEME; HYDROXYMETHYLBILANE SYNTHASE; KIDNEY; LEAD; LEAD POISONING; LIVER; MALE; MICROSOMES, LIVER; MIXED FUNCTION OXYGENASES; PORPHOBILINOGEN SYNTHASE; RATS; SULFHYDRYL COMPOUNDS;

EID: 0032020569     PISSN: 08953988     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Appenroth, D. (1994). The ambiguous effect of ascorbic acid on chromate induced proteinuria in rats. Arch. toxicol. 68, 138-141.
2. Basu, N. and Kulsreshtha, T. (1994). Effect of lead on plasma phenylbutazone levels in rats. Ind. J. Physiol. Pharmacol. 38, 61-62.
3. Burch, H. B. and Siegel, A. L. (1971). Improved method for measurement of delta aminolevulinic acid dehydratase activity of human erythrocytes. Clin. Chem. 17, 1038-1041.
4. Calabrese, E. J. (1978). Pollutant and High Risk Groups, p. 264. Wiley-Interscience, New York.
5. Chatterjee, G. C., Majumdar, P. K., Bannerjee, S. K., Roy, R. K., Ray, B., and Rudrapal, D. (1975). Relationship of protein and mineral intake to ascorbic acid metabolism, including considerations of some directly related hormones. Ann. N. Y. Acad. Sci. 258, 382-400.
6. Cochin, J. and Axelrod, J. (1959). Biochemical and pharmacological changes in the rat following chronic administration of morphine and normorphine. J. Pharmacol. Exp. Ther. 125, 105-110.
7. Dawson, E. B., Harris, W. A., and Powell, L. C. (1988). Apparent differences in nutritional status due to work environment. Faseb J. 2, A1431.
8. Degkwitz, E. and Staudinger, H. J. (1974). Role of vitamin C on microsomal cytochromes. In Vitamin C: Recent Aspects of Its Physiological and Technological Importance (Birch G. G., Parker, K. eds), pp. 161-178. Applied Science Publishers Ltd., London.
9. Degkwitz, E., Wallsch S., Dubberstein, M., and Winter, J. (1975). Ascorbic acid and cytochromes. Ann. N. Y. Acad. Sci. 258, 241-208.
10. Dhawan, M., Kachru, D. N., and Tandow, S. K. (1988). Influence of thiamine and ascorbic acid supplementation on the antidotal efficacy of thiol chelators in experimental lead intoxication. Arch. Toxicol. 62, 301-304.
11. Dirks, M. J., Davis, D. R., Emanuel, C., and Jackson, J. A. (1994). Mercury excretion and intravenous ascorbic acid. Arch. Environ. Hlth. 49, 49-52.
12. Farakas, C. S. (1978). Importance of interactions between nutrients and environmental contaminants as a factor is experimental design in toxicological research: with emphasis on selenium and ascorbic acid. Sci. Total Environ. 9, 149-159.
13. Farant, J. E. and Wigfield, D. C. (1987). Interaction of divalent metal ions with normal and lead inhibited human erythrocytic porphobilinogen synthase in vivo. Toxicol. Appl. Pharmacol. 89, 9-18.
14. Flora, S. J. S. and Tandon, S. K. (1986). Preventive and therapeutic effects of thiamine, ascorbic acid or their combination in lead intoxication. Acta Pharmacol. et Toxicol. 58, 374-378.
15. Goldberg, A., Meridith, S., Miller, M. R., and thompson, G. G. (1978). Hepatic drug metabolism and heme biosynthesis in lead poisoned rats. Br. J. Pharmacol. 62, 529-536.
16. Goyer, R. A. and Cherian, M. G. (1979). Ascorbic acid and EDTA treatment in lead poisoning. Life Sci. 24, 433-438.
17. Hessel, D. W. (1968). A simple and rapid quantitative determination of lead in blood. Atomic Absorption Newsletter 7, 55-56.
18. Imai, Y., Ito, A., and Sato, R. (1966). Evidence for biochemically different types of vesicles in hepatic microsomal fraction. Jap. J. Biochem. 60, 417-428.
19. Koichi, H., Shoko, O., Megumi, N., and Hajime, M. (1990). Effect of lead on drug metabolizing enzymes, cytochrome P450 and heme oxygenase. Sangyo Igaku 32, 33-40.
20. Lauwery, R., Harry, R., Buchet J. P., Bernard, A. A., Verboeve, L., and Kornings, J. (1983). The influence of orally administered vitamin C or zinc on the absorption of and biological response to lead. J. Occup. Med. 25, 668-673.
21. Levin, E. Y. and Coleman, D. L. (1967). The enzymatic conversion of porphobilinogen to uroporphyrinogen catalyzed by extracts of heamtopoietic mouse spleen. J. Biol. Chem. 242, 4248-4254.
22. Lowry, O. H., Rosebrough, N. J., Farr, A. L., and Randall, R. J. (1951). Protein measurement with Folin-phenol reagent. J. Biol. Chem. 255, 265-275.
23. Martinez, T. L., Osario, M. L., German, F. C., Ramirez, M. B., and Galar, C. I. (1992). Effect of lead on p-nitroanisole biodegradation by aquatic flea, Moina macrocopa. Int. J. Toxicol. Occup. Envirion. Hlth. 1, 74-76.
24. Meister, A. (1992). Commentary on the antioxidant effect of ascorbic acid and glutathione. Biochem. Pharmacol. 44, 1905-1915.
25. Neal, R. A. and Dubois, K. P. (1965). Studies on the mechanism of detoxification of cholinergic phosphorothoates. J. Pharmacol. Expt. Therap. 148, 185-192.
26. Nehru, B. and Kaushal, S. (1992). Effect of lead on hepatic microsomal enzyme activity. J. Appl. Toxicol. 12, 401-405.
27. Niazi, S., Lim, J., and Bederka, J. P. (1982). Effect of ascorbic acid on renal excretion of lead in rat. J. Pharmac. Sci. 71, 1189-1190.
28. Papaidannou, R., Sohler, A., and Pfeiffer, C. C. (1978). Reduction of blood lead levels in battery workers by zinc and vitamin C. J. Orthomed. Psychiatry 7, 94-106.
29. Petering, H. G. (1980). The influence of dietary zinc and copper on the biological effects of orally ingested lead in the rat. Ann. N. Y. Acad. Sci. 355, 298-308.
30. Pillemer, R., Seifter, J., Kuchn, A. O., and Ecter, E. E. (1940). Vitamin C in chronic lead poisoning. An experimental study. Amer. J. Med. Sci. 200, 322-327.
31. Roels, H. A., Buchet, J. P., and Lauwerys, R. A. (1974). Inhibition of human erythrocyte-aminolevulinate dehydratse by lead. In vitro artifact or real phenomenon in vivo. Int. Arch. Arbeitsmed. 33, 277-284.
32. Rudrapal, D., Chatterjee, J., and Chatterjee, G. C. (1975). Influence of lead administration on L ascorbic acid metabolism in rats: effect of L ascorbic acid acid supplementation. Int. J. Vit. Res. 45, 429-437.
33. Scoppa, P., Roumengono, M., and Penning, W. (1973). Hepatic drug metabolizing activity in lead poisoned rats. Experimentia 29, 970-972.
34. Sedlak, J. and Lindsay, R. H. (1968). Estimation of total, protein bound and nonprotein sulfhydryl groups in tissues with Ellman's reagent. Anal. Biochem. 25, 192-205.
35. Smithard, D. J. and Langman M. J. S. (1978). The effect of vitamin supplementation upon antipyrene metabolism in the elderly. Br. J. Clin. Pharmac. 5, 181-186.
36. Stoytchev, T. S. and Kadiiska, M. (1983). On the mechanism of the inhibitory effect of some heavy metal salts on the mixed function oxidizing enzyme system. Dev. Toxicol. Env. Sci. 11, 329-332.
37. Yeager, D. W., Cholak, J., and Henderson, E. W. (1971). Determination of lead in biological and related material by atomic absorption spectrometry. Environ. Sci. Technol. 5, 1020-1022.
38. Zannoni, V. G., Lynch, M. M., Goldstein, S., and Sato, P. H. (1974). Rapaid micro method for the determination of ascorbic acid in plasma and tissue. Biochem. Med. 11, 41-48.